VARIABLES AFFECTING PRICING OF ORPHAN DRUGS: THE ITALIAN CASE

被引:0
|
作者
Jommi, C. [1 ]
Listorti, E. [1 ]
Villa, F. [2 ]
Ghislandi, S. [3 ]
Genazzani, A. [4 ]
Cangini, A. [5 ]
Trotta, F. [5 ]
机构
[1] Bocconi Univ, SDA Bocconi Sch Management, Milan, MI, Italy
[2] Astrazeneca, Milan, Italy
[3] Bocconi Univ, Milan, Italy
[4] A Avogadro Univ, Novara, Italy
[5] AIFA Natl Med Agcy, Rome, Italy
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
POSC207
引用
收藏
页码:S148 / S148
页数:1
相关论文
共 50 条
  • [1] Variables affecting pricing of orphan drugs: the Italian case
    Jommi, Claudio
    Listorti, Elisabetta
    Villa, Federico
    Ghislandi, Simone
    Genazzani, Armando
    Cangini, Agnese
    Trotta, Francesco
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [2] Variables affecting pricing of orphan drugs: the Italian case
    Claudio Jommi
    Elisabetta Listorti
    Federico Villa
    Simone Ghislandi
    Armando Genazzani
    Agnese Cangini
    Francesco Trotta
    Orphanet Journal of Rare Diseases, 16
  • [3] Pricing of orphan drugs
    Leonard, J. V.
    Richmond, S.
    LANCET, 2009, 373 (9662): : 462 - 462
  • [4] Pricing and reimbursement of orphan drugs in Italy
    Lopatriello, S.
    Schivazappa, C.
    Negrini, C.
    Berto, P.
    VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
  • [5] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
    Kumar, J.
    Bachman, E. M.
    VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
  • [6] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN
    Cheng, C. Y.
    Chan, H. W.
    Fang, C. H.
    VALUE IN HEALTH, 2019, 22 : S856 - S856
  • [7] Orphan drugs: pricing, reimbursement and patient access
    Barak, Adam
    Nandi, Jyoti Shankar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2011, 5 (04) : 299 - 317
  • [8] Pricing and reimbursement of orphan drugs: the need for more transparency
    Steven Simoens
    Orphanet Journal of Rare Diseases, 6
  • [9] Pricing and reimbursement of orphan drugs: the need for more transparency
    Simoens, Steven
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [10] ORPHAN DRUGS: HEALTH TECHNOLOGY ASSESSMENT AND PRICING IN EUROPE
    Jaroslawski, S.
    Toumi, M.
    Korchagina, D.
    Jadot, G.
    VALUE IN HEALTH, 2018, 21 : S24 - S24